Clincosm LogoSign in Get a demo

Lymphoma

Showing NaN - NaN of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +15 more
Dec 7, 2022

Lymphoma Trial in Worldwide (Parsaclisib)

Active, not recruiting
Has Results
  • Lymphoma
  • Phoenix, Arizona
  • +82 more
Oct 14, 2022

Lymphoma Trial in United States (biological, drug, radiation)

Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
Sep 23, 2022

Solid Tumor, Lymphoma Trial in China, United States (TJ011133, Pembrolizumab, Rituximab)

Active, not recruiting
  • Solid Tumor
  • Lymphoma
  • Birmingham, Alabama
  • +20 more
Aug 22, 2022

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting
  • Multiple Myeloma
  • +5 more
  • Duarte, California
  • +38 more
Aug 18, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
Has Results
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Collecting and Storing Tissue From Young Patients With Cancer

Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
Aug 4, 2022

Solid Tumors, Lymphoma Trial in Worldwide (Ulevostinag, Pembrolizumab)

Completed
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +18 more
Jun 10, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

Recruiting
  • Brain and Central Nervous System Tumors
  • +8 more
  • 3'-deoxy-3'-[18F]fluorothymidine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 30, 2022

Lymphoma Trial in Worldwide (Parsaclisib)

Completed
Has Results
  • Lymphoma
  • Birmingham, Alabama
  • +69 more
Feb 28, 2022

Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)

Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +3 more
  • Greenbrae, California
  • +226 more
Mar 7, 2022

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Lymphoma Trial in Worldwide (Nivolumab)

Completed
Has Results
  • Lymphoma
  • Birmingham, Alabama
  • +49 more
Nov 24, 2021

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
Oct 25, 2021

Lymphoma Trial in United States (rituximab, bendamustine HCl, cyclophosphamide)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +8 more
  • Duarte, California
  • +203 more
Oct 14, 2021

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
Jan 7, 2021

Advanced Solid Tumor, Lymphoma Trial in United States (Milademetan)

Completed
  • Advanced Solid Tumor
  • Lymphoma
  • Detroit, Michigan
  • +4 more
Dec 4, 2020

Lymphoma Trial in United States (Tomivosertib (eFT-508))

Terminated
  • Lymphoma
  • Tomivosertib (eFT-508)
  • Los Angeles, California
  • +9 more
Oct 30, 2020

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit, Cleveland, Philadelphia (educational

Completed
  • Brain and Central Nervous System Tumors
  • +8 more
  • educational intervention
  • Detroit, Michigan
  • +3 more
Jul 23, 2020